The 2009-2014 World Outlook for Chiral-Based Products


January 8, 2009
191 Pages - SKU: ICN2098673
License type:
Countries covered: Global

This econometric study covers the world outlook for chiral-based products across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.

This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the 230 countries of the world). This study gives, however, my estimates for the worldwide latent demand, or the P.I.E. for chiral-based products. It also shows how the P.I.E. is divided across the world’s regional and national markets. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.



More Drug Discovery reports by Icon Group International, Inc.

The 2013-2018 Outlook for Cancer Therapy Pharmaceuticals in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for cancer therapy pharmaceuticals across the states and cities of the United States. Latent demand (in millions ...
The 2009-2014 World Outlook for Erythropoietins by Icon Group International, Inc.
This econometric study covers the world outlook for erythropoietins across more than 200 countries. For each year reported, estimates are given for the latent demand, ...
The 2010-2015 World Outlook for Drug Discovery Technologies by Icon Group International, Inc.
This econometric study covers the world outlook for drug discovery technologies across more than 200 countries. For each year reported, estimates are given for the ...
The 2009-2014 World Outlook for Botulinum Toxin by Icon Group International, Inc.
This econometric study covers the world outlook for botulinum toxin across more than 200 countries. For each year reported, estimates are given for the latent ...
See all reports like this >>

More Global Drug Discovery reports

Radiculopathy Global Clinical Trials Review, H1, 2013 by GlobalData
Radiculopathy Global Clinical Trials Review, H1, 2013SummaryGlobalData's clinical trial report, “Radiculopathy Global Clinical Trials Review, H1, 2013 provides data on the Radiculopathy clinical trial scenario. ...
Dystonia Global Clinical Trials Review, H1, 2013 by GlobalData
Dystonia Global Clinical Trials Review, H1, 2013SummaryGlobalData's clinical trial report, “Dystonia Global Clinical Trials Review, H1, 2013 provides data on the Dystonia clinical trial scenario. ...
Dyskinesia Global Clinical Trials Review, H1, 2013 by GlobalData
Dyskinesia Global Clinical Trials Review, H1, 2013SummaryGlobalData's clinical trial report, “Dyskinesia Global Clinical Trials Review, H1, 2013 provides data on the Dyskinesia clinical trial scenario. ...
Diverticulitis Global Clinical Trials Review, H1, 2013 by GlobalData
Diverticulitis Global Clinical Trials Review, H1, 2013SummaryGlobalData's clinical trial report, “Diverticulitis Global Clinical Trials Review, H1, 2013 provides data on the Diverticulitis clinical trial scenario. ...
See all reports like this >>

 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!